Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medical research is all about hard facts and statistics, but historically, and increasingly today, there is a lot of disinformation out there.

What medical professionals should do about this problem is the focus of the Paul Dudley White International Lecture presented by Sir Rory Collins, Professor of Medicine and Epidemiology at the Clinical Trial Service Unit at the Nuffield Department of Health, University of Oxford.

“The failure of the medical community, including medical journals and medical regulators, to act fast enough and robustly enough has left a long-term effect on public health. One of the most well known examples of disinformation in medicine was the false link between the measles, mumps and rubella vaccine and an increased risk for young children developing autism. This disinformation led to substantially decreased immunisation rates, the loss of herd immunity and increases in measles cases in Britain and the United States." said Professor Collins.

He will also discuss statin therapy and claims of large differences in the risk of side effects based on whether one looks at observational studies or randomised clinical trials. In observational studies, where researchers assess reports among people who know they are taking a statin, claims have been made that up to 20 percent of people experience side effects. In contrast, there’s a lack of increase in symptomatic side effects among people in randomised blinded trials, where people do not know whether they are taking statins or placebo.

The lecture honours Paul Dudley White, who is widely regarded as the founder of preventive cardiology. White helped found the Boston Society for the Prevention and Relief of Heart Disease (now the Greater Boston Division of the American Heart Association). He joined forces with similar groups in New York City and Philadelphia, and in 1924 became one of the founders of the AHA. He served as AHA president in 1941.

 

Forthcoming events

Title TBC

Monday, 15 April 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

The effects of BCG on non-specific resistance to respiratory infection

Monday, 13 May 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Title TBC

Monday, 20 May 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms